TheEdgeResearch
Home / Stocks / UNRV

Unrivaled Brands, Inc. (UNRV)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▼ -7.41%
Market Cap
$58,125
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.71
52-Wk Range
0.007-3.6
CEO
Sabas Carrillo
Country
US
Currency
USD

Unrivaled Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Santa Ana, CA, US. The stock last traded at $0.01, down 7.41% on the session, giving a market capitalisation of $58,125. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of -370.8%. Its beta of 2.71 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.02
Price / Sales
0.00
Price / Book
-0.12
EV / EBITDA
-0.27
Gross margin
32.5%
Operating margin
-372.5%
Net margin
-370.8%
Return on equity
Debt / equity
-1.36
Current ratio
0.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
151
IPO date
2012-05-10
Headquarters
Santa Ana, CA, US
About Unrivaled Brands, Inc.

Unrivaled Brands, Inc. is a vertically integrated cannabis company, managing cultivation, production, distribution, and retail operations for medical and adult-use products across California, Oregon, and Nevada. Founded in 2010, the company is headquartered in Santa Ana, California. It previously operated under the name Terra Tech Corp. before officially rebranding as Unrivaled Brands, Inc. in July 2021.

Comparable companies

Unrivaled Brands, Inc. is most often compared with the following Healthcare names:

CRXTQENDPGWPCHHPHFNLBSNMHLYOTRKPOTNRVRCSGBI
More research on UNRV
UNRV technical analysis UNRV TheEdge Score Compare against peers
Open full interactive analysis & DCF →